| Literature DB >> 27699191 |
Bong-Seok Jo1, In-Uk Koh2, Jae-Bum Bae2, Ho-Yeong Yu2, Eun-Seok Jeon3, Hae-Young Lee4, Jae-Joong Kim5, Murim Choi6, Sun Shim Choi1.
Abstract
Alterations in DNA methylation and gene expression have been implicated in the development of human dilated cardiomyopathy (DCM). Differentially methylated probes (DMPs) and differentially expressed genes (DEGs) were identified between the left ventricle (LV, a pathological locus for DCM) and the right ventricle (RV, a proxy for normal hearts). The data in this DiB are for supporting our report entitled "Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy" (Bong-Seok Jo, In-Uk Koh, Jae-Bum Bae, Ho-Yeong Yu, Eun-Seok Jeon, Hae-Young Lee, Jae-Joong Kim, Murim Choi, Sun Shim Choi, 2016) [1].Entities:
Keywords: DCM; DEG; DMP; Methylome; Transcriptome
Year: 2016 PMID: 27699191 PMCID: PMC5035344 DOI: 10.1016/j.dib.2016.09.006
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1Analysis of the relationship between DNA methylation levels and gene expression. (A) A diagram showing the 984 overlapping genes between DMP-containing genes and DEGs. (B) Bar graphs showing the proportions of up- and down-regulated gene expression levels and up- and down-regulated DNA methylation levels. Red and blue indicate negative and positive relationships, respectively, between methylation levels and expression levels. ‘Up’ and ‘Down’: up- and down-regulated expression levels, respectively; ‘Hyper’ and ‘Hypo’: up- and down-regulated methylation levels, respectively.
Fig. 2Methylation density of Up-/Down-DEGs in DHS and enhancer regions. Gene pairs with the top 20% of up-regulated expression fold-changes and bottom 20% of down-regulated expression fold-changes were selected among the 984 DMP–DEG pairs. The x-axis represent the fold-changes in methylation levels between RV and LV; negative values and positive values represent ‘Hypo’ and ‘Hyper’, respectively. The densities of ‘Hypo’ and ‘Hyper’ are plotted on the left (i.e., less-than-zero side) and right side (greater-than-zero side), respectively. The red lines represent the methylation densities of genes with the top 20% of up-regulated expression fold-changes (‘Up’), whereas the blue lines represent the methylation density of genes with the bottom 20% of down-regulated expression fold-changes (‘Down’).
Fig. 3Functional network of DMP genes matched to DEGs by the Reactome pathway. Network lines represent an interaction in which mutual proteins are involved in the similar reaction. The eight top-ranked functional sub-networks with many nodes (genes) were selected from the 984 genes included in the input genes list. The most significant functional term in each sub-network was selected to indicate the pathway of each sub-network. The down- and up-regulation of expression in each sub-network was determined by the log2-transformed average fold change of the mean expression of the genes in a particular sub-network and colored blue and red, respectively. TSS1500 or TSS200 in a sub-network indicates that the DMP positions were relatively enriched in that sub-network. The bold black border of the nodes indicates hypermethylation in LV, whereas the gray border of nodes indicates hypomethylation in LV; the red area indicates grouped genes with up-regulated expression, whereas the blue area indicates grouped genes with down-regulated expression.
List of the 45 genes characterized by GREAT.
| ALX homeobox 4 | |
| Rho guanine nucleotide exchange factor (GEF) 10 | |
| ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | |
| BCL2 binding component 3 | |
| B-cell CLL/lymphoma 2 | |
| BR serine/threonine kinase 2 | |
| DnaJ (Hsp40) homolog, subfamily C, member 10 | |
| Engrailed homeobox 1 | |
| Fibroblast growth factor 10 | |
| Fibroblast growth factor 8 (androgen-induced) | |
| Forkhead box C1 | |
| Forkhead box C2 (MFH-1, mesenchyme forkhead 1) | |
| Forkhead box E3 | |
| Forkhead box F1 | |
| Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 | |
| Heart and neural crest derivatives expressed 1 | |
| Homeobox A3 | |
| Homeobox A5 | |
| Homeobox D11 | |
| ISL LIM homeobox 1 | |
| Inositol 1,4,5-trisphosphate receptor, type 1 | |
| MDS1 and EVI1 complex locus | |
| msh homeobox 2 | |
| Myosin binding protein C, cardiac | |
| Myosin, light chain 2, regulatory, cardiac, slow | |
| NK2 homeobox 5 | |
| Notch 1 | |
| Odd-skipped related transcription factor 2 | |
| Protein phosphatase 1, regulatory subunit 13 like | |
| Pentatricopeptide repeat domain 2 | |
| Rap guanine nucleotide exchange factor (GEF) 3 | |
| Recombination signal binding protein for immunoglobulin kappa J region | |
| Retinol dehydrogenase 10 (all-trans) | |
| Ryanodine receptor 2 (cardiac) | |
| SIX homeobox 1 | |
| SMAD family member 3 | |
| T-box 5 | |
| Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | |
| Transforming growth factor, beta receptor III | |
| Thyroid hormone receptor, alpha | |
| Transmembrane BAX inhibitor motif containing 6 | |
| Tumor necrosis factor receptor superfamily, member 10b | |
| Troponin C type 1 (slow) | |
| Twist family bHLH transcription factor 1 | |
| Wingless-type MMTV integration site family, member 7A |
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility | |